Follow The Filings

CRWS

Earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by CRWS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CRWS insider trades
  • $96K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Donald R Ratajczak Director
    Buy
    $14K 5,000 shares at $2.70 +1.5% to stake
    Traded Nov 19, 2025 Filed Nov 21, 2025
    ↗
  2. Donald R Ratajczak Director
    Buy
    $82K 30,000 shares at $2.75 +10% to stake
    Traded Nov 13–17 Filed Nov 17, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 5 stock grants and 2 gifts.

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
8-K 4.01,9.01 Filing Doc
8-K 2.02,5.02,5.07,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
DEF 14A FORM DEF 14A Filing Doc
DEFA14A FORM DEFA14A Filing Doc
10-K FORM 10-K Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 2.02,5.07,9.01 Filing Doc
DEF 14A FORM DEF 14A Filing Doc
DEFA14A FORM DEFA14A Filing Doc
10-K FORM 10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
8-K 1.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 2.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.